Mussats Chicago practice, the goal is to empower you with education, compassionate care, and effective treatment that aligns with your esthetic ideals and health goals
Starting at $79/month
The genetic test identifies whether you carry variants associated with impaired satiety signaling, reduced GLP-1 receptor sensitivity, or fat mass dysregulation
This is why interest in Melanotan II now extends beyond cosmetics - researchers are also studying it in relation to sexual and metabolic disorders
This is where MeAgain's GLP-1 app fits in: it centralizes dose timelines, symptom and hydration logs, and lab entries, enabling clinicians to interpret test changes more quickly and precisely
The concept of an intermediate state post-ETI is pivotal (Maher et al., 2024): patients are significantly better, but their molecular profiles do not fully normalize to that of healthy individuals